Schim JD, Anderson C, Brunner E, Hirman J, et al. Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo-controlled randomized clinical trials. Headache 2022 May 6. doi: 10.1111/head.14302.
PMID: 35524405